[Effectiveness and cost-effectiveness of including HPV genotyping in cervical cancer screening]
Gutiérrez-Pizarraya A, Maesa-Márquez JM, Rodríguez López R, Blasco-Amaro JA, Jódar Sánchez F, García-Agua-Soler N, González-Álvarez ML, García-Ruiz AJ
Record ID 32018015761
Spanish
Original Title:
Eficacia y coste-efectividad de incluir el genotipado de VPH en el cribado de cáncer de cérvix
Details
Project Status:
Completed
URL for project:
https://www.aetsa.org/publicacion/eficacia-y-coste-efectividad-de-incluir-el-genotipado-de-vph-en-el-cribado-de-cancer-de-cervix/
Year Published:
2026
URL for published report:
https://www.aetsa.org/download/publicaciones/126_2024_AETSA_GenotipadoVPH_web.pdf
Requestor:
Spanish Health Ministry
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Spain
DOI:
10.52766/NWDQ7431
MeSH Terms
- Uterine Cervical Neoplasms
- Mass Screening
- Genotype
- Papillomavirus Infections
- Papillomaviridae
- Human papillomavirus 18
- Uterine Cervical Dysplasia
- Genotyping Techniques
- Human papillomavirus 16
- Early Detection of Cancer
- Cost-Effectiveness Analysis
- Human Papillomavirus DNA Tests
Contact
Organisation Name:
Andalusian Health Technology Assessment Area
Contact Address:
Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name:
aetsa.csalud@juntadeandalucia.es
Contact Email:
aetsa.csalud@juntadeandalucia.es
Copyright:
<p>Andalusian Agency for Health Technology Assessment (AETSA)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.